Recursion Pharmaceuticals, Inc. RXRX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s net margin?
- Recursion Pharmaceuticals, Inc. (RXRX) reported net margin of -842.9% in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s net margin changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s net margin increased by 12.3% year-over-year, from -961.3% to -842.9%.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s net margin?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s net margin has grown at a -17.0% compound annual growth rate (CAGR), from -2,196% to -863.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.